Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is -84.70% lower on its value in year-to-date trading and has touched a low of $2.19 and a high of $26.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RCKT stock was last observed hovering at around $3.2 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $3.16, the stock is 12.30% and -27.58% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.49 million and changing -1.25% at the moment leaves the stock -68.74% off its SMA200. RCKT registered -74.86% loss for a year compared to 6-month loss of -74.41%. The firm has a 50-day simple moving average (SMA 50) of $4.3634 and a 200-day simple moving average (SMA200) of $10.10985.
The stock witnessed a 4.64% gain in the last 1 month and extending the period to 3 months gives it a -34.03%, and is 9.72% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.57% over the week and 7.72% over the month.
Rocket Pharmaceuticals Inc (RCKT) has around 299 employees, a market worth around $340.45M and $0.00M in sales. Distance from 52-week low is 44.29% and -88.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-59.37%).
The EPS is expected to grow by 18.96% this year
325.0 institutions hold shares in Rocket Pharmaceuticals Inc (RCKT), with institutional investors hold 96.07% of the company’s shares. The shares outstanding are 106.75M, and float is at 99.77M with Short Float at 14.07%. Institutions hold 93.45% of the Float.
The top institutional shareholder in the company is RTW INVESTMENTS, LP with over 17.69 million shares valued at $380.82 million. The investor’s holdings represent 18.8677 of the RCKT Shares outstanding. As of 2024-06-30, the second largest holder is WELLINGTON MANAGEMENT GROUP LLP with 9.16 million shares valued at $197.12 million to account for 9.7665 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.19 million shares representing 6.6057 and valued at over $133.33 million, while VANGUARD GROUP INC holds 6.196 of the shares totaling 5.81 million with a market value of $125.06 million.
Rocket Pharmaceuticals Inc (RCKT) Insider Activity
The most recent transaction is an insider sale by Ondrey Aaron, the company’s Chief Financial Officer. SEC filings show that Ondrey Aaron sold 1,477 shares of the company’s common stock on Jul 03 ’25 at a price of $2.88 per share for a total of $4257.0. Following the sale, the insider now owns 0.13 million shares.
Still, SEC filings show that on May 20 ’25, Militello John disposed off 357 shares at an average price of $6.45 for $2301.0. The insider now directly holds 64,027 shares of Rocket Pharmaceuticals Inc (RCKT).
